We will be presenting at the @Oppenheimer Annual Healthcare Life Sciences Conference on February 14. We’re excited to connect with #investors to showcase our plans to advance a new class of precision #geneticmedicine. Learn more: bit.ly/3SnWwYc #OPCOLifeSciences

Our CEO, Brian McVeigh will be sharing his experience at the @GoodwinLaw & @KPMG_US 5th Annual Symposium during the @JPMorgan Healthcare Conference. Learn more: bit.ly/3Rv4MXl #JPM24

We’re thrilled to be attending the @JPMorgan Healthcare Conference in a few weeks! We are looking forward to sharing our progress in developing our novel non-viral 3DNA platform and pipeline that overcomes current #geneticmedicine delivery challenges. See you there! #JPM24

Code Bio recently hosted a #fooddrive in collaboration with @mannaonmain, an organization committed to ending hunger in the North Penn region. As a result of our team’s incredible support, we donated 408 pounds of food that will help feed members of our community in need.

Our CSO, Dave Anderson, and CBO, Lauren Kaskiel represented Code Bio at the @ESGCT 30th Annual Congress! Check out these behind-the-scenes snapshots as they network and collaborate with industry leaders. #ESGCT

Our Chief Scientific Officer, David Anderson, is presenting for Code Bio at @ChardanCM's Genetic Medicines Conference. This conference highlights genetic medicines through fireside chats, presentations and panel discussions: bit.ly/3LIc7zl #CGMC2023 #ChardanGMConf

Join Code Bio at the @LS_CaresPhilly Mini Golf FUN-raiser on September 21 at 4 pm. All funds raised support LSC PHL's grant-making efforts in support of nonprofit partners. Register here: bit.ly/3R1lFJw

CEO, Brian McVeigh is moderating the “Managing the Runway” panel at the @LongwoodLeaders conference on September 19. The event brings together #BioPharma leaders in a networking and brainstorming forum. #LongwoodHealthcareLeaders bit.ly/3QZD1GA

Our non-viral #3DNA® platform facilitates the precise delivery of #geneticmedicine by enabling the targeting of organs and cells specifically associated with the disease. Here’s how it works: bit.ly/3XsOTBY

Our CEO Brian McVeigh was interviewed as part of the @WuXi_AppTec “BOLD” online series discussing how Code Bio is pioneering a new class of #geneticmedicines to enable the precise and targeted delivery of treatments via our novel DNA delivery platform 3DNA bit.ly/3YfmTSK